Skip to Content
MarketWatch

This brewing fight in Congress could boost gold and sink stocks over the next 2 weeks

By MarketWatch

MARKETWATCH FRONT PAGE

Many investors may be taken by surprise as lawmakers battle over government spending.

FDA panel recommends Pfizer's COVID-19 booster for 65 and older, but not for the general public

A group of advisors to the Food and Drug Administration on Friday reframed a proposed approval of BioNTech and Pfizer's COVID-19 booster for the general population, and it instead recommended authorization of an additional dose of the vaccine to people at least 65 years old and those at high risk for severe disease.

Savvy stock traders use these 2 insider tips to know when to buy and sell

MACD and the MACD-Histogram can give your trading portfolio a boost.

We want to retire in the Carolinas or Virginias in a walkable town neither too large nor too small -- where should we go?

A local theater or museum would be nice.

If there were a 'Big Three' of electric vehicle makers, who would join Tesla?

Some EV companies have confirmed that no revenue will be forthcoming for the rest of this year, raising questions about who will survive and thrive in the space.

MARKETWATCH PERSONAL FINANCE

Lots of potential vacation-home buyers are on the fence, betting that the market will improve for buyers this fall as companies order workers back to the office while either reducing or completely eliminating remote work.

-MarketWatch

 

(END) Dow Jones Newswires

09-18-21 1700ET

Copyright (c) 2021 Dow Jones & Company, Inc.